ExacTrac Patient Positioning System with software versions 6.0, 6.1, 6.2, 6.5 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Brainlab Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2018-RN-00137-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2018-02-12
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    When using exactrac on a varian clinac or varian truebeam system equipped with the adi, beam requests of the treatment application have to be authorized by exactrac to enable treatment. as per the ifu, if no patient data is loaded in exactrac, exactrac always authorizes every beam request from the varian side. this is required and intended for clinical treatments where exactrac is not used for patient positioning. brainlab is clarifiying that the beam authorization by exactrac via adi is not a safety feature to ensure correct patient positioning before treatment.For any treatments performed with exactrac always verify that exactrac confirms the target position by displaying the ok icon. if a deviation of the patient position from the planned treatment position remains undetected by the user and the actual treatment beam that has been previously authorized by exactrac via adi is initialized, underdose of the planned target and/or overdose of healthy tissue could occur.
  • 조치
    Brainlab is advising users to always follow the IFU during use and to verify that ExacTrac confirms the target position by displaying the OK icon. Brainlab is providing updated Instructions for use. For treatments that have already been performed, the actual patient position during treatment can be reviewed in the treatment report of ExacTrac, and by using the Review function in the ExacTrac software.

Device

  • 모델명 / 제조번호(시리얼번호)
    ExacTrac Patient Positioning System with software versions 6.0, 6.1, 6.2, 6.5ARTG Number: 121226 (Brainlab Australia Pty Ltd - ExacTrac / Novalis Body - Patient positioning device, diagnostic imaging/radiotherapy, whole body)
  • Manufacturer

Manufacturer